Your browser doesn't support javascript.
loading
High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experience.
Said, Ebada Mohamed; Abdulaziz, Badawy A; El Kassas, Mohamed; El Attar, Ibrahim Hussein; Emadeldeen, Mohammed; Abd-Elsalam, Sherief M.
Afiliação
  • Said EM; Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Benha University, Benha, Egypt.
  • Abdulaziz BA; Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Benha University, Benha, Egypt.
  • El Kassas M; Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
  • El Attar IH; Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Benha University, Benha, Egypt.
  • Emadeldeen M; National Hepatology and Tropical Medicine Research Institute (NHTMRI), Cairo, Egypt.
  • Abd-Elsalam SM; Tropical Medicine Department, Tanta University, Tanta, Egypt. sherif.abdelbaky@med.tanta.edu.eg.
Arch Virol ; 165(7): 1633-1639, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32356185
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arch Virol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arch Virol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito